Emergent Biosolutions Q3 2021 Financial Performance Analysis
Wednesday, 6 March 2024, 21:50
Emergent Biosolutions Q3 2021 Financial Results Analysis
Emergent Biosolutions announced its financial results for the third quarter of 2021, revealing a Non-GAAP EPS of -$0.77, missing expectations by $0.45. However, the company's revenue stood at $276.6M, exceeding estimates by $2.6M. The quarterly report indicates a mixed performance for Emergent Biosolutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.